Nonsteroidal anti-inflammatory drugs in end-stage kidney disease: dangerous or underutilized?

Introduction: Nonsteroidal anti-inflammatory drugs (NSAIDs) are a popular class of analgesic and anti-inflammatory medications, but their use is often avoided in end-stage kidney disease (ESKD) patients due to their reputation for nephrotoxic side effects. This removes a useful agent from the analgesic arsenal, even as ESKD patients suffer from proportionally more severe chronic pain than the general population as well as from a large reliance on opioid medications. Areas Covered: This paper reviews the current literature to comprehensively define the pharmacologic mechanisms and adverse effects of NSAIDs and reassesses the viability of their use in ESKD patients. Expert opinion: The evidence directly examining the impact of NSAIDs on long-term outcomes in ESKD is limited. Further study quantifying the risk of NSAID use - especially in dialysis-dependent patients - is warranted. Given the difficulty in achieving adequate pain control in ESKD patients, limited use of NSAIDs in these patients may yet be justified.

Keywords: Nonsteroidal Anti-Inflammatory Drugs; analgesic prescription; chronic kidney disease; end-stage kidney disease; pain management.

Similar articles

Han Y, Balkrishnan R, Hirth RA, Hutton DW, He K, Steffick DE, Saran R. Han Y, et al. JAMA Netw Open. 2020 Sep 1;3(9):e2016839. doi: 10.1001/jamanetworkopen.2020.16839. JAMA Netw Open. 2020. PMID: 32997126 Free PMC article.

Pétureau A, Raffray M, Polard E, Couchoud C, Vigneau C, Bayat S. Pétureau A, et al. J Nephrol. 2021 Oct;34(5):1711-1723. doi: 10.1007/s40620-020-00952-5. Epub 2021 Apr 20. J Nephrol. 2021. PMID: 33877637

Liao YC, Chang CC, Chen TL, Liu CC, Chen HH, Lee YW. Liao YC, et al. J Nephrol. 2021 Apr;34(2):441-449. doi: 10.1007/s40620-020-00830-0. Epub 2020 Aug 25. J Nephrol. 2021. PMID: 32840754

Baker M, Perazella MA. Baker M, et al. Am J Kidney Dis. 2020 Oct;76(4):546-557. doi: 10.1053/j.ajkd.2020.03.023. Epub 2020 May 30. Am J Kidney Dis. 2020. PMID: 32479922 Review.

Jones P, Dalziel SR, Lamdin R, Miles-Chan JL, Frampton C. Jones P, et al. Cochrane Database Syst Rev. 2015 Jul 1;(7):CD007789. doi: 10.1002/14651858.CD007789.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2020 Aug 12;8:CD007789. doi: 10.1002/14651858.CD007789.pub3. PMID: 26130144 Updated. Review.

Cited by

Anders HJ, Li Q, Steiger S. Anders HJ, et al. Clin Kidney J. 2023 Jan 10;16(6):928-938. doi: 10.1093/ckj/sfad006. eCollection 2023 Jun. Clin Kidney J. 2023. PMID: 37261000 Free PMC article. Review.

Stamp LK, Farquhar H, Pisaniello HL, Vargas-Santos AB, Fisher M, Mount DB, Choi HK, Terkeltaub R, Hill CL, Gaffo AL. Stamp LK, et al. Nat Rev Rheumatol. 2021 Oct;17(10):633-641. doi: 10.1038/s41584-021-00657-4. Epub 2021 Jul 30. Nat Rev Rheumatol. 2021. PMID: 34331037 Free PMC article. Review.

Publication types